Who owns Cue Biopharma Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cue Biopharma stock

Who bought or sold Cue Biopharma Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Bleichroeder 5.0M $5.4M 0% Dec 2024
 View chart
Vanguard Group 2.1M $2.2M 1% Dec 2024
 View chart
BlackRock 639k $697k 12% Dec 2024
 View chart
Geode Capital Management 631k $688k 24% Dec 2024
 View chart
Robertson Stephens Wealth Management 479k $522k 0% Dec 2024
 View chart
Sigma Planning 447k $487k 11% Dec 2024
 View chart
Good Life Advisors 400k $436k 0% Dec 2024
 View chart
Bank of America Corporation 324k $354k 36% Dec 2024
 View chart
Advisory Research 257k $280k 0% Dec 2024
 View chart
Stifel Financial 211k $230k 9% Dec 2024
 View chart
Northern Trust 208k $208k 51% Dec 2024
 View chart
State Street Corporation 190k $207k 7% Dec 2024
 View chart
GSA Capital Partners 150k $163k -49% Dec 2024
 View chart
HighTower Advisors 128k $140k 54% Dec 2024
 View chart
Millennium Management 69k $76k -81% Dec 2024
 View chart
Jane Street 64k $70k 146% Dec 2024
 View chart
UBS Group 58k $64k -21% Dec 2024
 View chart
Hrt Financial 49k $53k 100% Dec 2024
 View chart
XTX Topco 47k $51k 70% Dec 2024
 View chart
LPL Financial 43k $47k 139% Dec 2024
 View chart
Goldman Sachs Group 35k $38k 86% Dec 2024
 View chart
Texas Capital Bank Wealth Management Services 33k $36k 100% Dec 2024
 View chart
Morgan Stanley 29k $31k -15% Dec 2024
 View chart
Point72 Asia 28k $30k 15% Dec 2024
 View chart
Navalign 25k $27k 100% Dec 2024
 View chart
Susquehanna International 25k $27k 100% Dec 2024
 View chart
Wells Fargo & Company 20k $22k 0% Dec 2024
 View chart
Cambridge Investment Research Advisors 20k $22k 0% Dec 2024
 View chart
Squarepoint Ops 20k $22k 100% Dec 2024
 View chart
Virtu Financial 17k $18k 100% Dec 2024
 View chart
SeaCrest Wealth Management 13k $14k 0% Dec 2024
 View chart
Citadel Advisors 12k $13k -29% Dec 2024
 View chart
Tower Research Capital 11k $12k 46% Dec 2024
 View chart
Beacon Pointe Advisors 10k $11k 0% Dec 2024
 View chart
Simplex Trading 6.9k $7.0k 70% Dec 2024
 View chart
Barclays 6.0k $7.0k 0% Dec 2024
 View chart
Gleason Group 6.0k $6.5k 0% Dec 2024
 View chart
Cubist Systematic Strategies 3.7k $4.0k 100% Dec 2024
 View chart
Newbridge Financial Services Group 3.0k $3.3k 0% Dec 2024
 View chart
Goss Wealth Management 2.6k $2.8k 0% Dec 2024
 View chart
Northwestern Mutual Wealth Management Company 2.5k $2.7k 0% Dec 2024
 View chart
Golden State Wealth Management 2.0k $2.2k 100% Dec 2024
 View chart
Larson Financial Group 1.4k $1.5k 0% Dec 2024
 View chart
Jpmorgan Chase & Co 1.1k $1.2k 17% Dec 2024
 View chart
UMA Financial Services 1.0k $1.1k 100% Dec 2024
 View chart
Bnp Paribas Arbitrage, Snc 854.00 $931.030800 7% Dec 2024
 View chart
MAI Wealth Advisors 350.00 $381.990000 100% Dec 2024
 View chart
Sunbelt Securities 237.00 $242.000700 0% Dec 2024
 View chart
Armstrong Advisory Group 120.00 $131.004000 0% Dec 2024
 View chart
IFP Advisors 100.00 $109.000000 0% Dec 2024
 View chart
FMR 96.00 $105.004800 -66% Dec 2024
 View chart
Point72 66.00 $71.999400 14% Dec 2024
 View chart
Stonebridge Financial Group 62.00 $68.001600 100% Dec 2024
 View chart
Citigroup 43.00 $46.999000 0% Dec 2024
 View chart
SBI Securities 1.00 $1.000000 100% Dec 2024
 View chart

Who sold out of Cue Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
Slate Path Capital Sep 2024 2.4M $1.8M
Qube Research & Technologies Sep 2024 25k $19k
Mirae Asset Global Etfs Holdings Jun 2024 18k $22k
Dimensional Fund Advisors Sep 2024 15k $11k
Legacy Capital Group California Sep 2024 10k $7.6k
Catalyst Funds Management Pty Jun 2024 9.0k $11k
Harbour Investments Sep 2024 439.00 $332.015700
Advisor Group Holdings Sep 2024 380.00 $288.002000
SRS Capital Advisors Sep 2024 215.00 $162.991500